Skip to main content
. Author manuscript; available in PMC: 2011 Oct 27.
Published in final edited form as: Ophthalmology. 2009 Jan;116(1):106–115.e1. doi: 10.1016/j.ophtha.2008.10.013

Table 1.

Availability of Photograph Gradings and Reasons for No Photograph Grading by Year of Follow-up for 650 Patients in the Collaborative Ocular Melanoma Study (COMS), Randomized to and Treated by Iodine-125 Brachytherapy

Reason Baseline 2 Years 5 Years 8 Years
Photos were taken and gradable for at least some features 648 (99.7%) 493 (75.8%) 318 (48.9%) 162 (24.9%)
Patient not eligible for photos* 0 (0%) 0 (0%) 0 (0%) 136 (20.9%)
Patient had died 0 (0%) 24 (3.7%) 116 (17.8%) 136 (20.9%)
Eye enucleated 0 (0%) 30 (4.6%) 60 (9.2%) 51 (7.8%)
Patient missed clinic examination 0 (0%) 51 (7.8%) 65 (10.0%) 98 (15.1%)
Patient had clinic examination, but photos were not taken 0 (0%) 29 (4.5%) 65 (10.0%) 50 (7.7%)
Photos were taken but not gradable for any feature 2 (0.3%) 23 (3.5%) 26 (4.0%) 17 (2.6%)
Total 650 650 650 650
*

Patient had not reached the follow-up time in question by the time of close of clinical follow-up in the COMS.